These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12379691)
1. Role of interferon-stimulated gene factor 3gamma and beta interferon in HLA class I enhancement in synovial fibroblasts upon infection with Chlamydia trachomatis. Rödel J; Vogelsang H; Prager K; Hartmann M; Schmidt KH; Straube E Infect Immun; 2002 Nov; 70(11):6140-6. PubMed ID: 12379691 [TBL] [Abstract][Full Text] [Related]
2. Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts. Rödel J; Groh A; Hartmann M; Schmidt KH; Lehmann M; Lungershausen W; Straube E Med Microbiol Immunol; 1999 May; 187(4):205-12. PubMed ID: 10363677 [TBL] [Abstract][Full Text] [Related]
3. Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression. Rödel J; Groh A; Vogelsang H; Lehmann M; Hartmann M; Straube E Infect Immun; 1998 Sep; 66(9):4491-5. PubMed ID: 9712805 [TBL] [Abstract][Full Text] [Related]
4. HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia induced Reiter's disease. Hermann E; Mayet WJ; Thomssen H; Sieper J; Poralla T; Meyer zum Büschenfelde KH; Fleischer B J Rheumatol; 1992 Aug; 19(8):1243-6. PubMed ID: 1404160 [TBL] [Abstract][Full Text] [Related]
5. Interferon-beta induction by Chlamydia pneumoniae in human smooth muscle cells. Rödel J; Assefa S; Prochnau D; Woytas M; Hartmann M; Groh A; Straube E FEMS Immunol Med Microbiol; 2001 Dec; 32(1):9-15. PubMed ID: 11750216 [TBL] [Abstract][Full Text] [Related]
6. Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis. Rödel J; Straube E; Lungershausen W; Hartmann M; Groh A J Rheumatol; 1998 Nov; 25(11):2161-8. PubMed ID: 9818659 [TBL] [Abstract][Full Text] [Related]
7. Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Bas S; Kvien TK; Buchs N; Fulpius T; Gabay C Rheumatology (Oxford); 2003 Mar; 42(3):461-7. PubMed ID: 12626797 [TBL] [Abstract][Full Text] [Related]
8. Defective induction of the transcription factor interferon-stimulated gene factor-3 and interferon alpha insensitivity in human trophoblast cells. Cross JC; Lam S; Yagel S; Werb Z Biol Reprod; 1999 Feb; 60(2):312-21. PubMed ID: 9915996 [TBL] [Abstract][Full Text] [Related]
9. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of the JAK/STAT1 signal pathway during Chlamydia trachomatis infection. Lad SP; Fukuda EY; Li J; de la Maza LM; Li E J Immunol; 2005 Jun; 174(11):7186-93. PubMed ID: 15905563 [TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88. Nagarajan UM; Ojcius DM; Stahl L; Rank RG; Darville T J Immunol; 2005 Jul; 175(1):450-60. PubMed ID: 15972679 [TBL] [Abstract][Full Text] [Related]
12. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Nanagara R; Li F; Beutler A; Hudson A; Schumacher HR Arthritis Rheum; 1995 Oct; 38(10):1410-7. PubMed ID: 7575691 [TBL] [Abstract][Full Text] [Related]
13. Direct evidence that interferon-beta mediates enhanced HLA-class I expression in measles virus-infected cells. Dhib-Jalbut SS; Cowan EP J Immunol; 1993 Dec; 151(11):6248-58. PubMed ID: 8245464 [TBL] [Abstract][Full Text] [Related]
14. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. Gaston JS; Deane KH; Jecock RM; Pearce JH J Rheumatol; 1996 Jan; 23(1):130-6. PubMed ID: 8838521 [TBL] [Abstract][Full Text] [Related]
15. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. Zhong G; Liu L; Fan T; Fan P; Ji H J Exp Med; 2000 May; 191(9):1525-34. PubMed ID: 10790427 [TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition. Matyszak MK; Gaston JS Infect Immun; 2004 Aug; 72(8):4357-67. PubMed ID: 15271891 [TBL] [Abstract][Full Text] [Related]
17. Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Cuchacovich R; Espinoza LR Rheumatology (Oxford); 2004 Feb; 43(2):249-50; author reply 250-1. PubMed ID: 14739472 [No Abstract] [Full Text] [Related]
18. Human Fallopian Tube Epithelial Cell Culture Model To Study Host Responses to Chlamydia trachomatis Infection. McQueen BE; Kiatthanapaiboon A; Fulcher ML; Lam M; Patton K; Powell E; Kollipara A; Madden V; Suchland RJ; Wyrick P; O'Connell CM; Reidel B; Kesimer M; Randell SH; Darville T; Nagarajan UM Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32601108 [No Abstract] [Full Text] [Related]
19. Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway. Vanover J; Sun J; Deka S; Kintner J; Duffourc MM; Schoborg RV Microbiology (Reading); 2008 Mar; 154(Pt 3):971-978. PubMed ID: 18310043 [TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]